Active Crohn's Disease Patients Show a Distinctive Expansion of Circulating Memory CD4+CD45RO+CD28null T Cells
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
In a previous study we found an expansion of circulating memory (CD45RO(+)) CD4(+) T cells in patients with Crohn's disease (CD). The aim of this work was to investigate the phenotypic and functional characteristics of this T-cell subset in CD. We analyzed in peripheral blood CD4(+)CD45RO(+) T cells from CD patients the expression of surface markers associated to immune activation, costimulation, and apoptosis. In sorted CD4(+)CD45RO(+) T cells apoptosis was quantified by fluorescent annexin V binding. Healthy subjects and patients with ulcerative colitis and acute bacterial enterocolitis served as control groups. An increased percentage of memory CD4(+)CD45RO(+) T cells lacking the expression of costimulatory receptor CD28 was detected in patients with active CD when compared to the other groups evaluated. This expanded CD4(+)CD45RO(+)CD28(null) T-cell subset expressed mostly the effector-cell marker CD57(+). Both CD28 downregulation and CD57 expression correlated to CDAI and surrogate markers of disease activity. These phenotypic changes observed on CD4(+)CD45RO(+) T cells from active CD returned to values similar to healthy controls after clinical remission. Moreover, this memory CD28(null) T-cell subset might express more intracytoplasmic TNF and IFN-gamma than their CD28(+) counterpart. Significantly lower frequencies of memory CD4(+)CD45RO(+) T cells expressing CD95 apoptosis receptor were found in patients with active CD. Moreover, sorted CD4(+)CD45RO(+)and CD4(+)CD45R…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Effector memory CD4 + T-cells lacking CD28 expression have been reported in humans, but only in association with autoimmune diseases such as rheumatoid arthritis, Crohn's disease or multiple sclerosis (Markovic-Plese et al., 2001;Fasth et al., 2004;Garcia de Tena et al., 2004), and were not observed with the healthy donors used in this study.”
From Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T‐cells (2010) · cites this paper as Garcia de Tena et al., 2004
Citations
Cites
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 2×
“Under normal circumstances, around 50% of human CD8 C T cells and virtually all human CD4 C T lymphocytes express CD28 ( 25 ).”
BackgroundInflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059 · cited 2×
“Gut segment involved Ileal ( 1 ), Ileal (5), Rectum (2), Rectum (4), — —”
BackgroundClassification of Inflammatory Bowel Disease
Lennard-Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,011 · cited 1×
“CD and UC diagnoses were based on clinical, radiological, endoscopic, and pathologic bases ( 17 ).”
MethodPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
The B7 and CD28 receptor families
June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90080-9 · Cited by 1,296
Dutton, R. W., Bradley, L. M., & Swain, S. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.201 · Cited by 832 · cited 1×
“Gut segment involved Ileal (1), Ileal ( 5 ), Rectum (2), Rectum (4), — —”
BackgroundNatalizumab for Active Crohn's Disease
Ghosh, S., Goldin, E., Gordon, F. H., Malchow, H. A., Rask-Madsen, J., Rutgeerts, P., Vyhnálek, P., Zádorová, Z., Palmer, T., & Donoghue, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020732 · Cited by 808 · cited 1×
“In line with these biological findings, the therapeutic efficacy in CD of a monoclonal antibody against the fi4 integrin adhesion molecule (natalizumab) ( 50 ) has recently been published, emphasizing the importance of the recirculation and homing in the clinicopathological activity of the disease.”
ResultTreatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Epidemiology of inflammatory bowel disease
Loftus, E. V., & Sandborn, W. J. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00002-4 · Cited by 542
Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110033251406 · Cited by 541
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1954) · BMJ · doi:10.1136/bmj.2.4884.375 · Cited by 538
Sprent, J., & Surh, C. D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100101.151926 · Cited by 534
Schmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Shanahan, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07284-7 · Cited by 478
Perturbation of the T-cell repertoire in patients with unstable angina.
Liuzzo, G., Kopecky, S. L., Frye, R. L., Fallon, W. M. O., Maseri, A., Goronzy, J. J., & Weyand, C. M. (1999) · Circulation · doi:10.1161/01.cir.100.21.2135 · Cited by 398
Generation and maintenance of memory CD4+ T Cells
van Leeuwen, E. M., Sprent, J., & Surh, C. D. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.02.005 · Cited by 300
CD28 costimulation promotes the production of Th2 cytokines
Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W., & Bluestone, J. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.658 · Cited by 291
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis
Martens, P. B., Goronzy, J. J., Schaid, D., & Weyand, C. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400615 · Cited by 290
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12516 · Cited by 243 · cited 2×
“In addition, functional assays in patients with immune-mediated disorders demonstrated that this T-cell subset is autoreactive ( 31 , 35).”
BackgroundFunctional subsets of CD4 T cells in rheumatoid synovitis
Namekawa, T., Wagner, U. G., Goronzy, J. J., & Weyand, C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2108::aid-art5>3.0.co;2-q · Cited by 242 · cited 1×
“Moreover, they display an increased production of proinflammatory cytokines (33, 36‐38) as well as cytotoxic capacity (37, 39 , 40) raising the hypothesis that the expansion of CD4 C CD28 null T cells found in such diseases may have a pathogenic role in the development of these disorders (31, 35).”
BackgroundCD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112516 · Cited by 210
Komocsi, A., Lamprecht, P., Csernok, E., Mueller, A., Holl-Ulrich, K., Seitzer, U., Moosig, F., Schnabel, A., & Gross, W. L. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61118-2 · Cited by 206
Seder, R. A., Germain, R. N., Linsley, P. S., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.299 · Cited by 205 · cited 1×
“However, it has become clear that CD28ligand interactions could play other complex multiple roles including ablation of the immune response leading to tolerance (26), alteration of the Th1/Th2 balance ( 27 , 28), and regulation of cytolytic effector activity (29).”
BackgroundDubey, C., Croft, M., & Swain, S. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3280 · Cited by 196
Vallejo, A. N., Nestel, A. R., Schirmer, M., Weyand, C. M., & Goronzy, J. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8119 · Cited by 182
Generation and maintenance of memory T cells
Sprent, J., & Surh, C. D. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00211-9 · Cited by 181
Kraan, M. C., van Kuijk, A. W. R., Dinant, H. J., Goedkoop, A. Y., Smeets, T. J. M., de Rie, M. A., Dijkmans, B. A. C., Vaishnaw, A. K., Bos, J. D., & Tak, P. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10543 · Cited by 167
Moosig, F., Csernok, E., Wang, G., & Gross, W. L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00695.x · Cited by 138
Nakajima, T., Goek, O., Zhang, X., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2003) · Circulation Research · doi:10.1161/01.res.0000082333.58263.58 · Cited by 127 · cited 1×
“Moreover, they display an increased production of proinflammatory cytokines (33, 36‐38) as well as cytotoxic capacity (37, 39, 40 ) raising the hypothesis that the expansion of CD4 C CD28 null T cells found in such diseases may have a pathogenic role in the development of these disorders (31, 35).”
BackgroundMeenan, J. K., Spaans, J., Grool, T. A., Pals, S. T., Tytgat, G. N. J., & van Deventer, S. J. H. (1997) · Gut · doi:10.1136/gut.40.2.241 · Cited by 105
Duftner, C., Goldberger, C., Falkenbach, A., Würzner, R., Falkensammer, B., Pfeiffer, K. P., Maerker-Hermann, E., & Schirmer, M. (2003) · Arthritis Res Ther · doi:10.1186/ar793 · Cited by 103 · cited 1×
“Moreover, they display an increased production of proinflammatory cytokines (33, 36‐38) as well as cytotoxic capacity ( 37 , 39, 40) raising the hypothesis that the expansion of CD4 C CD28 null T cells found in such diseases may have a pathogenic role in the development of these disorders (31, 35).”
BackgroundCo‐stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells
Park, W., Weyand, C. M., Schmidt, D., & Goronzy, J. J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270507 · Cited by 101
Migration pathways and immunologic memory among T lymphocytes.
Mackay, C. R. (1992) · PubMed · Cited by 95
Chakir, J., Laviolette, M., Turcotte, H., Boutet, M., & Boulet, L.-P. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.110100 · Cited by 88
Crucian, B., Dunne, P., Friedman, H., Ragsdale, R., Pross, S., & Widen, R. (1995) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.2.2.249-252.1995 · Cited by 86
Roman, L. I., Manzano, L., de la Hera, A., Abreu, L., Rossi, I., & Álvarez‐Mon, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8612987 · Cited by 82
Self-citationThe immunology of inflammatory bowel disease
Plevy, S. E. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00006-1 · Cited by 79
Iwatani, Y., HIDAKA, V., Matsuzuka, F., Kuma, K., & Amino, N. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb08196.x · Cited by 77
Immunology of inflammatory bowel disease
McCabe, R. P., Dean, P., & Elson, C. O. (1996) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199607000-00005 · Cited by 64 · cited 3×
“Gut segment involved Ileal (1), Ileal (5), Rectum ( 2 ), Rectum (4), — —”
BackgroundInfluentialWarnier, G., Duffour, M., Uyttenhove, C., Gajewski, T. F., Lurquin, C., Haddada, H., Perricaudet, M., & Boon, T. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960717)67:2<303::aid-ijc24>3.0.co;2-a · Cited by 61 · cited 1×
“However, it has become clear that CD28ligand interactions could play other complex multiple roles including ablation of the immune response leading to tolerance (26), alteration of the Th1/Th2 balance (27, 28), and regulation of cytolytic effector activity ( 29 ).”
BackgroundThe enigma of CD57+CD28– T cell expansion—anergy or activation?
Kern, F., Ode-Hakim, S., Vogt, K., Höflich, C., Reinke, P., & Volk, H. D. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-635.x · Cited by 61
Autschbach, F., Qiao, L., Wallich, R., Meuer, S. C., Sch�rmann, G., & Merz, H. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00194698 · Cited by 61 · cited 1×
“mucosa (10). Moreover, the majority of mononuclear cells infiltrating the gut wall in CD do not express proliferation markers, suggesting that the accumulation of T lymphocytes, at least in part, is the result of an adhesionmediated increased influx from the peripheral blood rather than the effect of local cell prolif…”
BackgroundGarcía‐Suárez, J., Prieto, A., Reyes, E., Manzano, L., Merino, J., & Alvarez-Mon, M. (1993) · Blood · doi:10.1182/blood.v82.5.1538.1538 · Cited by 60
Self-citationGiscombe, R., Nityanand, S., Lewin, N. L., Grünewald, J., & Lefvert, A. K. (1998) · Journal of Clinical Immunology · doi:10.1023/a:1023230722874 · Cited by 52 · cited 1×
“Specifically, circulating CD4 C CD57 C T cells have been found increased in seropositive rheumatoid arthritis (44, 45) as well as other immune-mediated disorders (46, 47 ).”
BackgroundHogan, L. H., Markofski, W., Bock, A., Barger, B., Morrissey, J. D., & Sándor, M. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2596-2603.2001 · Cited by 51 · cited 1×
“In line with this, it has been demonstrated that M. bovis bacille Calmette-Gu´ erin-infected CD28-deficient mice retain the ability to mount a T-cell-mediated immune response capable to form granulomas ( 42 ).”
ResultImberti, L., Sottini, A., Signorini, S., Gorla, R., & Primi, D. (1997) · Blood · doi:10.1182/blood.v89.8.2822 · Cited by 51
Elevated B‐Lymphocyte Levels in Lesional Tissue of Non‐Arthritic Psoriasis
Mahmoud, F. F., Abul, H. T., Saleh, Q. A., Hassab‐El‐Naby, H. M. M., Kajeji, M., Haines, D. D., Burleson, J., & Morgan, G. (1999) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1999.tb02021.x · Cited by 39
I, A. P., Díaz, D., Barcenilla, H., García‐Suárez, J., Reyes, E., Monserrat, J., Antonio, E. S., Melero, D., de la Hera, A., Órfão, A., et al. (2002) · Cytometry · doi:10.1002/cyto.10132 · Cited by 39 · cited 2×
“Apoptosis after in vitro culture of T-cell subsets was quantified calculating the apoptotic rate (AR) according to a new method recently reported by our group ( 23 ).”
MethodSelf-citationWu, X.-M., Osoegawa, M., Yamasaki, K., Kawano, Y., Ochi, H., Horiuchi, I., Minohara, M., Ohyagi, Y., Yamada, T., & Kira, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00322-1 · Cited by 38 · cited 1×
“Ileocolonic ( 12 ), Ileocolonic (13), Distal colitis (6), Distal colitis (3),”
BackgroundGranstein, R. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450410 · Cited by 37
Involvement of CD4+,CD57+ T cells in the disease activity of rheumatoid arthritis
Maeda, T., Yamada, H., Nagamine, R., Shuto, T., Nakashima, Y., Hirata, G., & Iwamoto, Y. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10133 · Cited by 37 · cited 1×
“Specifically, circulating CD4 C CD57 C T cells have been found increased in seropositive rheumatoid arthritis (44, 45 ) as well as other immune-mediated disorders (46, 47).”
BackgroundMariani, P., Bachetoni, A., d’Alessandro, M., Lomanto, D., Mazzocchi, P., & Speranza, V. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005516730754 · Cited by 32 · cited 1×
“mucosa ( 10 ). Moreover, the majority of mononuclear cells infiltrating the gut wall in CD do not express proliferation markers, suggesting that the accumulation of T lymphocytes, at least in part, is the result of an adhesionmediated increased influx from the peripheral blood rather than the effect of local cell prol…”
BackgroundPrieto, A., Reyes, E., Díaz, D., Hernández-Fuentes, M. P., Monserrat, J., Perucha, E., Mu�oz, L., Vangioni, R., de la Hera, A., Órfão, A., et al. (2000) · Cytometry · doi:10.1002/(sici)1097-0320(20000101)39:1<56::aid-cyto8>3.0.co;2-v · Cited by 23 · cited 2×
“ers. Data were analyzed with Cell Quest software (Becton Dickinson) as previously described ( 22 ).”
MethodSelf-citationKweon, M.-N., Takahashi, I., Yamamoto, M., Jang, M. H., Suenobu, N., & Kiyono, H. (2002) · Gut · doi:10.1136/gut.50.3.299 · Cited by 18 · cited 1×
“... lymphocytes with potential effector capability, it is reasonable to propose that this subpopulation might be implicated in the clinicopathological expression of CD. In this regard, it is interesting to note that circulating primed activated/memory CD4 C CD45RB low T cells (the murine equivalent to human CD4 C CD45…”
BackgroundMartín, A. P., Reyes, E., Arriagada, F. C., Hernández-Fuentes, M. P., Vilaplana, J. C., García‐Suárez, J., & Álvarez‐Mon, M. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb00731.x · Cited by 14
Self-citation
Cited by
Eastwood, D., Findlay, L., Poole, S., Bird, C., Wadhwa, M., Moore, M., Burns, C., Thorpe, R., & Stebbings, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00922.x · Cited by 300
Inclusion body myositis: clinical features and pathogenesis
Greenberg, S. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0186-x · Cited by 273
Allez, M., Tieng, V., Nakazawa, A., Treton, X., Pacault, V., Dulphy, N., Caillat–Zucman, S., Paul, P., Gornet, J., Douay, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.025 · Cited by 231
Ueno, A., Jijon, H., Chan, R., Ford, K., Hirota, C., Kaplan, G. G., Beck, P. L., Iacucci, M., Fort Gasia, M., Barkema, H. W., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a85709 · Cited by 207
Fasth, A. E. R., Dastmalchi, M., Rahbar, A., Salomonsson, S., Pandya, J. M., Lindroos, E., Nennesmo, I., Malmberg, K.-J., Söderberg-Nauclér, C., Trollmo, C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803688 · Cited by 157
Metadata
- Authors
- De Tena, J. G., Manzano, L., Leal, J. C., Antonio, E. S., Sualdea, V., & Álvarez-Mon, M.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Venue
- Journal of Clinical Immunology
- Published
- 2004-03
- Volume
- 24
- Issue
- 2
- Pages
- 185-196
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2031601446
- Cited by
- 59
- References
- 58
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Crohn's disease, memory CD4+ T cells, CD45RO, CD57, apoptosis resistance, Fas, TNF-α, interferon-gamma, disease activity, clinical remission, ulcerative colitis, T cell costimulation
- MeSH terms
- Adult, Crohn Disease, Female, Humans, Immunologic Memory, Male, CD4-Positive T-Lymphocytes, Cytokines, Apoptosis, Leukocyte Common Antigens, CD28 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.